Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 1.05B | 3.6% |
| Gross Profit | 618M | 13.9% |
| Cost of Revenue | 436M | 8.2% |
| Operating expense | 276M | 16.8% |
| Net Income | 283M | 66.3% |
| EBITDA | 357M | 43.1% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 9.16B | 5.1% |
| Total Liabilities | 4.03B | 4% |
| Total Equity | 5.13B | 5.9% |
| Shares Outstanding | 223M | 5.4% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | 514M | 75.8% |
| Cash from investing | -582M | 1412.5% |
| Cash from financing | 50M | 1290.5% |
EPS
Financial Highlights for Hologic in Q3 '24
Hologic reported a revenue of 1.05B, which is a 3.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 618M, marking a 13.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 436M, a -8.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 276M, showing a -16.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 283M, showing a 66.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 357M, showing a 43.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Hologic with growth in revenue, gross profit, and net income.
